Artwork

Content provided by The PJ Pod and Pharmaceutical Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The PJ Pod and Pharmaceutical Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Meet the mAbs: the new treatments for vulnerable patients with COVID-19

23:25
 
Distribuie
 

Manage episode 323237391 series 3329558
Content provided by The PJ Pod and Pharmaceutical Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The PJ Pod and Pharmaceutical Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
There have been some promising trial results recently regarding the efficacy of monoclonal antibodies (or mAbs) in patients with COVID-19. In this podcast, features editor Dawn Connelly and clinical and science editor Julia Robinson investigate the science behind these exciting new treatments and the potential role of pharmacists in preparing, supplying and assessing patients for their use. Robinson also visits the aseptics lab at King's College Hospital in London to find out from senior pharmacist James Cheung how mAbs are made. With thanks to associate professor Al Edwards from the Reading School of Pharmacy and PJ deputy news editor Carolyn Wickware for their help in preparing this podcast. This episode was produced by Geoff Marsh. Our exclusive on NHS plans for a community-based mAbs service: https://tinyurl.com/mabsservice Here is a link to more information on the clinical trials discussed in this podcast: tinyurl.com/COVIDtxs
  continue reading

52 episoade

Artwork
iconDistribuie
 
Manage episode 323237391 series 3329558
Content provided by The PJ Pod and Pharmaceutical Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The PJ Pod and Pharmaceutical Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
There have been some promising trial results recently regarding the efficacy of monoclonal antibodies (or mAbs) in patients with COVID-19. In this podcast, features editor Dawn Connelly and clinical and science editor Julia Robinson investigate the science behind these exciting new treatments and the potential role of pharmacists in preparing, supplying and assessing patients for their use. Robinson also visits the aseptics lab at King's College Hospital in London to find out from senior pharmacist James Cheung how mAbs are made. With thanks to associate professor Al Edwards from the Reading School of Pharmacy and PJ deputy news editor Carolyn Wickware for their help in preparing this podcast. This episode was produced by Geoff Marsh. Our exclusive on NHS plans for a community-based mAbs service: https://tinyurl.com/mabsservice Here is a link to more information on the clinical trials discussed in this podcast: tinyurl.com/COVIDtxs
  continue reading

52 episoade

همه قسمت ها

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință

Listen to this show while you explore
Play